Cleared Traditional

K884849 - BIOFEEDBACK DEVICE ACCESS. PI1,2,3,4,5/LIGHT BAR

K884849 is an FDA 510(k) clearance for BIOFEEDBACK DEVICE ACCESS. PI1, manufactured by Moe. The device is a Class 2 Neurology device with product code HCC cleared through the Traditional 510(k) pathway after a 125-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1989
Decision
125d
Days
Class 2
Risk

K884849 is an FDA 510(k) clearance for the BIOFEEDBACK DEVICE ACCESS. PI1,2,3,4,5/LIGHT BAR. Classified as Device, Biofeedback (product code HCC), Class II - Special Controls.

Submitted by Moe (Soquel, US). The FDA issued a Cleared decision on March 23, 1989 after a review of 125 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5050 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K884849

510(k) Number K884849 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 18, 1988
Decision Date March 23, 1989
Days to Decision 125 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
24d faster than avg
Panel avg: 149d · This submission: 125d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HCC Device Classification - Class 2, Special Controls

Product Code HCC Device, Biofeedback
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - HCC Device, Biofeedback

All 172
Devices cleared under the same product code (HCC) and FDA review panel - the closest regulatory comparables to K884849.
MYODAC2 BIOFEEDBACK DEVICE
K894840 · Thought Technology , Ltd. · Oct 1989
AUTOMATED THERAPY SYSTEM
K891693 · Harding & Harris, Inc. · Aug 1989
LEUNOMED RFB 5000
K881164 · Hemodynamics, Inc. · Apr 1989
BIOFEEDBACK DEVICE TG3, TG4
K884851 · Moe · Feb 1989
BASIC BIOFEEDBACK,TMG4.1, SA1/2, EEG4/5, IR RECEIV
K884848 · Moe · Feb 1989
BIOFEEDBACK TMG1, 4, BIO1, PA1, 2, BA1/BA30
K884850 · Moe · Feb 1989